Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04082754
What this trial is testing

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Who this might be right for
Asthma
CSL Behring 78
Large-scale testing (Phase 3)Study completedNCT03018756
What this trial is testing

Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea

Who this might be right for
Interstitial Lung Disease
Dr. Denis O'Donnell 21
Testing effectiveness (Phase 2)Study completedNCT01808157
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Creabilis SA 188
Large-scale testing (Phase 3)WithdrawnNCT02176551
What this trial is testing

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

Who this might be right for
Atopic Dermatitis
Fougera Pharmaceuticals Inc.
Testing effectiveness (Phase 2)Study completedNCT04664153
What this trial is testing

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 104
Testing effectiveness (Phase 2)WithdrawnNCT06473974
What this trial is testing

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Who this might be right for
Facial Hyperpigmentation
Kayuraeffect, LLP
Early research (Phase 1)Looking for participantsNCT04271488
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants

Who this might be right for
Hepatic Impairment
Eisai Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03402503
What this trial is testing

Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
IntelGenx Corp. 52
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Testing effectiveness (Phase 2)Study completedNCT01583582
What this trial is testing

Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp

Who this might be right for
HypertensionBlood Pressure
Marealis AS 74
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Post-approval studies (Phase 4)Ended earlyNCT04656691
What this trial is testing

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Who this might be right for
Covid19
Daniel Griffin 139
Testing effectiveness (Phase 2)Study completedNCT01761227
What this trial is testing

Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia

Who this might be right for
Vascular Dementia
Dongzhimen Hospital, Beijing 240
Post-approval studies (Phase 4)Study completedNCT00150059
What this trial is testing

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis
Testing effectiveness (Phase 2)Study completedNCT00004192
What this trial is testing

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNeutropenia
University of Nebraska 60
Testing effectiveness (Phase 2)Ended earlyNCT04220411
What this trial is testing

AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Arjil Pharmaceuticals LLC 17
Testing effectiveness (Phase 2)Study completedNCT01094132
What this trial is testing

Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection

Who this might be right for
Cervical CancerPrecancerous Condition
British Columbia Cancer Agency 551
Large-scale testing (Phase 3)UnknownNCT03090516
What this trial is testing

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's
The First Affiliated Hospital with Nanjing Medical University 240
Post-approval studies (Phase 4)Looking for participantsNCT04314375
What this trial is testing

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 70
Early research (Phase 1)Study completedNCT02063230
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Who this might be right for
Solid Tumors
AstraZeneca 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation